Click here to discover the largest collection of GeneMedi's Promise-ORF™ ORF/cDNA expression clones
Plasmid quantity:
- 10mg, 50mg, 100mg, 500mg, >1g
Talk to our Expert:
- • Research Grade
- • Endotoxin-Free Grade
- • High Quality (HQ) Grade
TECHNICAL RESOURCE
Supports
- Talk to our Expert:
[email protected]
Protocol Library Download
 |
 |
Human IL17A/CTLA-8/CTLA8 ORF/cDNA clone-Lentivirus plasmid (NM_002190)
Cat. No.: pGMLP000168
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human IL17A/CTLA-8/CTLA8 Lentiviral expression plasmid for IL17A lentivirus packaging, IL17A lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Datasheet
Go to
IL-17A/IL17A/IL17/IL17A/CTLA-8 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMLP000168 |
| Gene Name | IL17A |
| Accession Number | NM_002190 |
| Gene ID | 3605 |
| Species | Human |
| Product Type | Lentivirus plasmid (overexpression) |
| Insert Length | 468 bp |
| Gene Alias | CTLA-8,CTLA8,IL-17,IL-17A,IL17 |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGACTCCTGGGAAGACCTCATTGGTGTCACTGCTACTGCTGCTGAGCCTGGAGGCCATAGTGAAGGCAGGAATCACAATCCCACGAAATCCAGGATGCCCAAATTCTGAGGACAAGAACTTCCCCCGGACTGTGATGGTCAACCTGAACATCCATAACCGGAATACCAATACCAATCCCAAAAGGTCCTCAGATTACTACAACCGATCCACCTCACCTTGGAATCTCCACCGCAATGAGGACCCTGAGAGATATCCCTCTGTGATCTGGGAGGCAAAGTGCCGCCACTTGGGCTGCATCAACGCTGATGGGAACGTGGACTACCACATGAACTCTGTCCCCATCCAGCAAGAGATCCTGGTCCTGCGCAGGGAGCCTCCACACTGCCCCAACTCCTTCCGGCTGGAGAAGATACTGGTGTCCGTGGGCTGCACCTGTGTCACCCCGATTGTCCACCATGTGGCCTAA |
| ORF Protein Sequence | MTPGKTSLVSLLLLLSLEAIVKAGITIPRNPGCPNSEDKNFPRTVMVNLNIHNRNTNTNPKRSSDYYNRSTSPWNLHRNEDPERYPSVIWEAKCRHLGCINADGNVDYHMNSVPIQQEILVLRREPPHCPNSFRLEKILVSVGCTCVTPIVHHVA |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Target information
| Target ID | GM-T22095 |
| Target Name | IL-17A/IL17A/IL17 |
|
Gene Group Identifier （Target Gene ID in Homo species) |
3605 |
| Gene ID |
100034142 (Equus caballus), 101095339 (Felis catus), 16171 (Mus musculus), 282863 (Bos taurus) 301289 (Rattus norvegicus), 3605 (Homo sapiens), 481837 (Canis lupus familiaris), 708123 (Macaca mulatta) |
| Gene Symbols & Synonyms | IL17A,Il17a,IL17,Il17,Ctla8,IL-17,Ctla-8,IL-17A,CTLA-8,CTLA8,ILA17 |
| Target Alternative Names | IL-17A, IL17A, IL17,Interleukin-17A,IL-17, IL-17A,Cytotoxic T-lymphocyte-associated antigen 8 (CTLA-8),IL17,CTLA8,IL-17,ILA17,CTLA-8,IL-17A |
| Uniprot Accession |
Q16552,Q61453,Q62386,Q687Y7
Additional SwissProt Accessions: Q62386,Q687Y7,Q61453,Q16552 |
| Uniprot Entry Name | |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | Therapeutics Target, Immuno-oncology Target, INN Index, Cytokine Target |
| Disease | cancer |
| Disease from KEGG | Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Th17 cell differentiation, Alcoholic liver disease, Inflammatory bowel disease, Rheumatoid arthritis |
| Gene Ensembl | ENSECAG00000038266, ENSMUSG00000025929, ENSBTAG00000002150, ENSG00000112115, ENSMMUG00000007403 |
| Target Classification | Checkpoint-Immuno Oncology, Tumor-associated antigen (TAA) |
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.